RoE Neuropathic Pain Market to 2032
Overview
The RoE Neuropathic Pain Market is expected to reach a 146.07 USD Billion by 2032 and is projected to grow at a CAGR of 12.63% from 2025 to 2032.
Revenue, 2024 (USD Billion)
78.34
Forecast, 2032 (USD Billion)
146.07
CAGR, 2024 - 2032
12.63%
Report Coverage
RoE
RoE Neuropathic Pain Market 2018-2032 USD Billion
RoE Neuropathic Pain Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 78.34 USD Billion
- Projected Market Size (2032): 146.07 USD Billion
- CAGR (2025-2032): 12.63%
Key Findings of RoE Neuropathic Pain Market
- The RoE Neuropathic Pain Market was valued at 146.07 USD Billion in 2024.
- The RoE Neuropathic Pain Market is likely to grow at a CAGR of 12.63% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Devices in Mode of Purchase Segment accounted for the largest share of the market with a revenue of 59.42 USD Billion
- The fastest growing segment Peripheral Neuropathy in Pain Type Segment grew Fastest with a CAGR of 15.95% during the forecast period from 2024 to 2032.
RoE Neuropathic Pain Market Scope
RoE Neuropathic Pain Market Segmentation & Scope
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Indication
- Others
- Diabetic Neuropathy
- Chemotherapy-Induced Peripheral Neuropathy
- Spinal Stenosis
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
RoE Neuropathic Pain Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 78.34 USD Billion |
| Market Value in 2032 | 146.07 USD Billion |
| CAGR (2025-2032) | 12.63% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Type,Pain Type,Indication,Product Type,Procedure,Technology,Modality,Mode of Purchase |
Regional Insights:
-
Leading Market (2024-2032): RoE, leading in terms of revenue 78.34 USD Billion in 2024
- Key Country: RoE, leading in terms of revenue with value of 78.34 USD Billion in 2024.
Segments and Scope
-
RoE Neuropathic Pain Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 51.36 USD Billion in the year 2024.
- Direct Tenders is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 12.94 % in forecast period 2025-2032.
-
RoE Neuropathic Pain Market to 2032, By End User
- Clinics is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 24.55 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 13.68 % in forecast period 2025-2032.
-
RoE Neuropathic Pain Market to 2032, By Type
- Spinal Cord Stimulation (SCS) Devices is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 47.97 USD Billion in the year 2024.
- Spinal Cord Stimulation (SCS) Devices is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 13.03 % in forecast period 2025-2032.
-
RoE Neuropathic Pain Market to 2032, By Pain Type
- Peripheral Neuropathy is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 17.88 USD Billion in the year 2024.
- Peripheral Neuropathy is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 15.95 % in forecast period 2025-2032.
-
RoE Neuropathic Pain Market to 2032, By Indication
- Spinal Stenosis is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 32.43 USD Billion in the year 2024.
- Chemotherapy-Induced Peripheral Neuropathy is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 12.45 % in forecast period 2025-2032.
-
RoE Neuropathic Pain Market to 2032, By Product Type
- Rechargeable is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 50.93 USD Billion in the year 2024.
- Non-Rechargeable is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 12.11 % in forecast period 2025-2032.
-
RoE Neuropathic Pain Market to 2032, By Procedure
- Non-Invasive is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 56.34 USD Billion in the year 2024.
- Non-Invasive is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 12.98 % in forecast period 2025-2032.
-
RoE Neuropathic Pain Market to 2032, By Technology
- Transcutaneous Electrical Nerve Stimulation is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 45.87 USD Billion in the year 2024.
- Transcutaneous Electrical Nerve Stimulation is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 13.07 % in forecast period 2025-2032.
-
RoE Neuropathic Pain Market to 2032, By Modality
- Portable is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 51.05 USD Billion in the year 2024.
- Stationary is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 12.44 % in forecast period 2025-2032.
-
RoE Neuropathic Pain Market to 2032, By Mode of Purchase
- Prescription-Based Devices is the largest segment in RoE Neuropathic Pain Market to 2032 with a revenue of 59.42 USD Billion in the year 2024.
- Prescription-Based Devices is the Fastest growing segment in RoE Neuropathic Pain Market to 2032 with a Growth rate of 12.80 % in forecast period 2025-2032.
RoE Neuropathic Pain Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Omron Healthcare, Inc. | |||
| NEVRO CORP. | |||
| Integer Holdings Corporation | |||
| Boston Scientific Corporation or its affiliates | |||
RoE Neuropathic Pain Market Geographical Sales Distribution, 2018-2032 USD Billion
RoE Neuropathic Pain Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoE Neuropathic Pain Market is segmented based on Segmentation Distribution Channel,End User,Type,Pain Type,Indication,Product Type,Procedure,Technology,Modality,Mode of Purchase.
RoE Neuropathic Pain Market was valued at USD 78.34(Revenue in USD Billion) in 2020.
RoE Neuropathic Pain Market is projected to grow at a CAGR of 12.63% during the forecast period of 2024 to 2032.
The Prescription-Based Devices segment is expected to dominate the RoE Neuropathic Pain Market, holding a largest market share of 59.42 USD Billion in 2024
RoE Neuropathic Pain Market Scope
RoE Neuropathic Pain Market Segmentation & Scope
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Indication
- Others
- Diabetic Neuropathy
- Chemotherapy-Induced Peripheral Neuropathy
- Spinal Stenosis
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Frequently Asked Questions
The RoE Neuropathic Pain Market is segmented based on Segmentation Distribution Channel,End User,Type,Pain Type,Indication,Product Type,Procedure,Technology,Modality,Mode of Purchase.
RoE Neuropathic Pain Market was valued at USD 78.34(Revenue in USD Billion) in 2020.
RoE Neuropathic Pain Market is projected to grow at a CAGR of 12.63% during the forecast period of 2024 to 2032.
The estimated market value of the RoE Neuropathic Pain Market for final year is USD 146.07 (USD Billion).
RoE Neuropathic Pain Market Company Profiling
Frequently Asked Questions
The RoE Neuropathic Pain Market is segmented based on Segmentation Distribution Channel,End User,Type,Pain Type,Indication,Product Type,Procedure,Technology,Modality,Mode of Purchase.
RoE Neuropathic Pain Market was valued at USD 78.34(Revenue in USD Billion) in 2020.
RoE Neuropathic Pain Market is projected to grow at a CAGR of 12.63% during the forecast period of 2024 to 2032.
The estimated market value of the RoE Neuropathic Pain Market for final year is USD 146.07 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.